Accolade will release fiscal Q3 2025 results on January 9, 2024, and host a conference call at 4:30 p.m. E.T.
Quiver AI Summary
Accolade, Inc. announced that it will release its fiscal third quarter 2025 financial results on January 9, 2024, after market close, and will host a conference call at 4:30 p.m. ET that same day. Participants can pre-register to listen by telephone or access the call via a live audio webcast on the company's investor relations website. A replay of the call will be available online for a year after its completion. Accolade is a Personalized Healthcare company focused on providing exceptional health experiences through various solutions, including virtual primary care and care navigation, achieving high consumer satisfaction ratings.
Potential Positives
- Accolade, Inc. is set to release its fiscal third quarter 2025 financial results, indicating transparency and communication with stakeholders.
- The scheduled conference call for discussing the financial results allows for direct engagement with investors and analysts.
- Accolade's consistent consumer satisfaction ratings of over 90% highlight the effectiveness of its personalized healthcare solutions and commitment to quality service.
- The company's innovative offerings in virtual primary care and mental health position it favorably within the growing personalized healthcare market.
Potential Negatives
- The announcement of a scheduled financial results release may indicate that the company is facing pressure to improve transparency after potential investor concerns regarding previous performance.
FAQ
When will Accolade release its Q3 financial results?
Accolade will release its fiscal third quarter 2025 financial results on January 9, 2024, after market close.
How can I listen to the conference call?
Listeners can join the conference call by pre-registering online or accessing it via the live audio webcast at Accolade's investor relations site.
Is a replay of the conference call available?
Yes, a replay of the call will be available online for one year after its completion at Accolade's website.
What services does Accolade offer?
Accolade provides personalized healthcare solutions, including virtual primary care, mental health services, expert medical opinions, and care navigation.
How can I contact Accolade's investor relations?
You can reach Accolade's investor relations by emailing Todd Friedman at IR@accolade.com.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ACCD Insider Trading Activity
$ACCD insiders have traded $ACCD stock on the open market 66 times in the past 6 months. Of those trades, 0 have been purchases and 66 have been sales.
Here’s a breakdown of recent trading of $ACCD stock by insiders over the last 6 months:
- RAJEEV SINGH (Chief Executive Officer) has traded it 18 times. They made 0 purchases and 18 sales, selling 27,340 shares.
- STEPHEN H. BARNES (Chief Financial Officer) has traded it 18 times. They made 0 purchases and 18 sales, selling 9,972 shares.
- ROBERT N CAVANAUGH (President) has traded it 18 times. They made 0 purchases and 18 sales, selling 10,155 shares.
- COLIN MCHUGH (Chief Accounting Officer) has traded it 6 times. They made 0 purchases and 6 sales, selling 4,707 shares.
- RICHARD ESKEW (EVP General Counsel) has traded it 6 times. They made 0 purchases and 6 sales, selling 5,272 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ACCD Hedge Fund Activity
We have seen 85 institutional investors add shares of $ACCD stock to their portfolio, and 94 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO removed 2,902,307 shares (-98.1%) from their portfolio in Q3 2024
- ROCK SPRINGS CAPITAL MANAGEMENT LP removed 2,129,783 shares (-93.0%) from their portfolio in Q3 2024
- ACADIAN ASSET MANAGEMENT LLC added 1,713,456 shares (+498.5%) to their portfolio in Q3 2024
- MILLENNIUM MANAGEMENT LLC added 1,364,682 shares (+52.0%) to their portfolio in Q3 2024
- PROSIGHT MANAGEMENT, LP added 1,312,073 shares (+88.1%) to their portfolio in Q3 2024
- WHETSTONE CAPITAL ADVISORS, LLC added 997,889 shares (+inf%) to their portfolio in Q3 2024
- D. E. SHAW & CO., INC. added 976,175 shares (+318.8%) to their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
SEATTLE, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal third quarter 2025 financial results on Thursday, January 9, 2024 after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.
Conference Call Details
To Listen via Telephone : Pre-registration is required by the conference call operator. Please pre-register by clicking here . (https://register.vevent.com/register/BI0dce2f02ed2f44c8901127623aa788c3) Upon registering, you will be emailed a dial-in number, direct passcode and unique PIN.
To Listen via Internet : The conference call can be accessed via a live audio webcast that will be available online at http://ir.accolade.com .
Replay : A replay of the call will be available for one year via webcast for on-demand listening shortly after the completion of the call, at http://ir.accolade.com .
About Accolade, Inc.
Accolade (Nasdaq: ACCD) is a Personalized Healthcare company that provides millions of people and their families with exceptional healthcare experiences so they can live their healthiest lives. Accolade’s employer, health plan, and consumer solutions combine virtual primary care and mental health, expert medical opinion, and best-in-class care navigation. These offerings are built on a platform that is engineered to care through predictive engagement of population health needs, proactive care that improves outcomes and cost savings, and by addressing barriers to access and continuity of care. Accolade consistently receives consumer satisfaction ratings of over 90%. For more information, visit accolade.com . Follow us on LinkedIn , Twitter , Instagram and Facebook .
Investor Contact:
Todd Friedman, Investor Relations, IR@accolade.com
Media Contact:
Media Inquiries, Media@accolade.com
Source: Accolade
This press release was published by a CLEAR® Verified individual.